Align Technology (NASDAQ:ALGN) shares plunged more than 23% after-hours following the company’s reported Q3 results, with EPS of $2.14 coming in worse than the consensus estimate of $2.27.
Revenue fell 4.2% sequentially and grew 7.8% year-over-year to $960.2 million, missing the consensus estimate of $998.68M.
"Our third quarter results reflect lower than expected demand and a more difficult macro environment than we experienced in the first half of 2023. Dental practices and industry research firms have reported deteriorating trends, including decreased patient visits and increased patient appointment cancellations, along with fewer orthodontic case starts overall, especially among adult patients,” said CEO Joe Hogan.
For Q4/23, the company expects revenue to be in the range of $0.92-$0.94 billion, below the consensus estimate of $1.02B. For the full year, revenue is expected to be in the range of $3.83-$3.85B, compared to the consensus estimate of $3.97B.